Manggubat, Bby. Girl .
HRN: 23-00-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/21/2023
05/28/2023
IVTT
40mg
Q24
Psnb
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes